Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus Infections
Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd., has entered into a...
Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19
Mateon Therapeutics, Inc dedicated to development OT-101, a TGF-β antisense drug candidate, announced that Mateon has delivered the requisite testing results to Golden Mountain...
Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research
Agilent Technologies Inc. (NYSE: A) introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.
The new Agilent...
Iktos, SRI join forces for AI-driven drug discovery to combat COVID-19 and other viruses
Iktos, a French artificial intelligence (AI) start-up company, has joined forces with California-based research institute SRI International to accelerate discovery and development of therapies...
Applied BioMath, LLC Announces Collaboration with Gritstone Oncology, Inc
Applied BioMath , the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a collaboration...
Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics
Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement...
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...